Clinical Trial Update: Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports that Berubicin in adults with recurrent glioblastoma multiforme (WHO Grade IV) in Phase 1/2 was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Berubicin (berubicin)

Snippet

Sponsor: WPD Pharmaceuticals Sp. z o.o. | Conditions: Recurrent Glioblastoma Multiforme | Phase 1, Phase 2 | Status: TERMINATED